Related references
Note: Only part of the references are listed.Homoharringtonine Exerts Anti-tumor Effects in Hepatocellular Carcinoma Through Activation of the Hippo Pathway
Haina Wang et al.
FRONTIERS IN PHARMACOLOGY (2021)
Exploring subclass-specific therapeutic agents for hepatocellular carcinoma by informatics-guided drug screen
Chen Yang et al.
BRIEFINGS IN BIOINFORMATICS (2021)
Bioinformatic analysis of RHO family of GTPases identifies RAC1 pharmacological inhibition as a new therapeutic strategy for hepatocellular carcinoma
Juan Bayo et al.
GUT (2021)
Pembrolizumab As Second-Line Therapy in Patients With Advanced Hepatocellular Carcinoma in KEYNOTE-240: A Randomized, Double-Blind, Phase III Trial
Richard S. Finn et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
Atezolizumab plus Bevacizumab in Unresectable Hepatocellular Carcinoma
Richard S. Finn et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Large-Scale Characterization of Drug Responses of Clinically Relevant Proteins in Cancer Cell Lines
Wei Zhao et al.
CANCER CELL (2020)
Network-based machine learning in colorectal and bladder organoid models predicts anti-cancer drug efficacy in patients
JungHo Kong et al.
NATURE COMMUNICATIONS (2020)
Discovering the anticancer potential of non-oncology drugs by systematic viability profiling
Steven M. Corsello et al.
NATURE CANCER (2020)
Proteomics identifies new therapeutic targets of early-stage hepatocellular carcinoma
Ying Jiang et al.
NATURE (2019)
Next-generation characterization of the Cancer Cell Line Encyclopedia
Mahmoud Ghandi et al.
NATURE (2019)
A Pharmacogenomic Landscape in Human Liver Cancers
Zhixin Qiu et al.
CANCER CELL (2019)
Integrated Proteogenomic Characterization of HBV-Related Hepatocellular Carcinoma (vol 179, pg 561, 2019)
Qiang Gao et al.
CELL (2019)
Breaking the paradigm: Dr Insight empowers signature-free, enhanced drug repurposing
Jinyan Chan et al.
BIOINFORMATICS (2019)
Ramucirumab after sorafenib in patients with advanced hepatocellular carcinoma and increased α-fetoprotein concentrations (REACH-2): a randomised, double-blind, placebo-controlled, phase 3 trial
Andrew X. Zhu et al.
LANCET ONCOLOGY (2019)
ChEMBL: towards direct deposition of bioassay data
David Mendez et al.
NUCLEIC ACIDS RESEARCH (2019)
Tumor-adjacent tissue co-expression profile analysis reveals pro-oncogenic ribosomal gene signature for prognosis of resectable hepatocellular carcinoma
Oleg V. Grinchuk et al.
MOLECULAR ONCOLOGY (2018)
Data Portal for the Library of Integrated Network-based Cellular Signatures (LINCS) program: integrated access to diverse large-scale cellular perturbation response data
Amar Koleti et al.
NUCLEIC ACIDS RESEARCH (2018)
EMUDRA: Ensemble of Multiple Drug Repositioning Approaches to improve prediction accuracy
Xianxiao Zhou et al.
BIOINFORMATICS (2018)
L1000FWD: fireworks visualization of drug-induced transcriptomic signatures
Zichen Wang et al.
BIOINFORMATICS (2018)
An Integrated TCGA Pan-Cancer Clinical Data Resource to Drive High-Quality Survival Outcome Analytics
Jianfang Liu et al.
CELL (2018)
Tyrosine kinase SYK is a potential therapeutic target for liver fibrosis
Chen Qu et al.
HEPATOLOGY (2018)
Risk factors and prevention of hepatocellular carcinoma in the era of precision medicine
Naoto Fujiwara et al.
JOURNAL OF HEPATOLOGY (2018)
Lenvatinib versus sorafenib in first-line treatment of patients with unresectable hepatocellular carcinoma: a randomised phase 3 non-inferiority trial
Masatoshi Kudo et al.
LANCET (2018)
Cabozantinib in Patients with Advanced and Progressing Hepatocellular Carcinoma
G. K. Abou-Alfa et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Homoharringtonine induced immune alteration for an Efficient Anti-tumor Response in Mouse Models of Non-small Cell Lung Adenocarcinoma Expressing Kras Mutation
Tzu-Yang Weng et al.
SCIENTIFIC REPORTS (2018)
The Library of Integrated Network-Based Cellular Signatures NIH Program: System-Level Cataloging of Human Cells Response to Perturbations
Alexandra B. Keenan et al.
CELL SYSTEMS (2018)
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Freddie Bray et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
Carcinogenesis on the background of liver fibrosis: Implications for the management of hepatocellular cancer
Joanne Marie O'Rourke et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2018)
Drug and disease signature integration identifies synergistic combinations in glioblastoma
Vasileios Stathias et al.
NATURE COMMUNICATIONS (2018)
A review of connectivity map and computational approaches in pharmacogenomics
Aliyu Musa et al.
BRIEFINGS IN BIOINFORMATICS (2018)
Computational Discovery of Niclosamide Ethanolamine, a Repurposed Drug Candidate That Reduces Growth of Hepatocellular Carcinoma Cells In Vitro and in Mice by Inhibiting Cell Division Cycle 37 Signaling
Bin Chen et al.
GASTROENTEROLOGY (2017)
Regorafenib for patients with hepatocellular carcinoma who progressed on sorafenib treatment (RESORCE): a randomised, double-blind, placebo-controlled, phase 3 trial
Jordi Bruix et al.
LANCET (2017)
Nivolumab in patients with advanced hepatocellular carcinoma (CheckMate 040): an open-label, non-comparative, phase 1/2 dose escalation and expansion trial
Anthony B. El-Khoueiry et al.
LANCET (2017)
Computational correction of copy number effect improves specificity of CRISPR-Cas9 essentiality screens in cancer cells
Robin M. Meyers et al.
NATURE GENETICS (2017)
The Drug Repurposing Hub: a next-generation drug library and information resource
Steven M. Corsello et al.
NATURE MEDICINE (2017)
Reversal of cancer gene expression correlates with drug efficacy and reveals therapeutic targets
Bin Chen et al.
NATURE COMMUNICATIONS (2017)
Common and cell-type specific responses to anti-cancer drugs revealed by high throughput transcript profiling
Mario Niepel et al.
NATURE COMMUNICATIONS (2017)
Characterization of gene expression profiles in HBV-related liver fibrosis patients and identification of ITGBL1 as a key regulator of fibrogenesis
Mingjie Wang et al.
SCIENTIFIC REPORTS (2017)
A Next Generation Connectivity Map: L1000 Platform and the First 1,000,000 Profiles
Aravind Subramanian et al.
CELL (2017)
Comprehensive and Integrative Genomic Characterization of Hepatocellular Carcinoma
Adrian Ally et al.
CELL (2017)
A survey of current trends in computational drug repositioning
Jiao Li et al.
BRIEFINGS IN BIOINFORMATICS (2016)
Neoangiogenesis-related genes are hallmarks of fast-growing hepatocellular carcinomas and worst survival. Results from a prospective study
Erica Villa et al.
GUT (2016)
Correlating chemical sensitivity and basal gene expression reveals mechanism of action
Matthew G. Rees et al.
NATURE CHEMICAL BIOLOGY (2016)
Transcriptional Characterization of Compounds: Lessons Learned from the Public LINCS Data
Hans De Wolf et al.
ASSAY AND DRUG DEVELOPMENT TECHNOLOGIES (2016)
Combenefit: an interactive platform for the analysis and visualization of drug combinations
Giovanni Y. Di Veroli et al.
BIOINFORMATICS (2016)
A gene-signature progression approach to identifying candidate small-molecule cancer therapeutics with connectivity mapping
Qing Wen et al.
BMC BIOINFORMATICS (2016)
Molecular Liver Cancer Prevention in Cirrhosis by Organ Transcriptome Analysis and Lysophosphatidic Acid Pathway Inhibition
Shigeki Nakagawa et al.
CANCER CELL (2016)
Whole-genome mutational landscape and characterization of noncoding and structural mutations in liver cancer
Akihiro Fujimoto et al.
NATURE GENETICS (2016)
Hepatocellular carcinoma
Josep M. Llovet et al.
NATURE REVIEWS DISEASE PRIMERS (2016)
Connectivity mapping using a combined gene signature from multiple colorectal cancer datasets identified candidate drugs including existing chemotherapies
Qing Wen et al.
BMC SYSTEMS BIOLOGY (2015)
The carbon tetrachloride model in mice
D. Scholten et al.
LABORATORY ANIMALS (2015)
Drugs that reverse disease transcriptomic signatures are more effective in a mouse model of dyslipidemia
Allon Wagner et al.
MOLECULAR SYSTEMS BIOLOGY (2015)
Exome sequencing of hepatocellular carcinomas identifies new mutational signatures and potential therapeutic targets
Kornelius Schulze et al.
NATURE GENETICS (2015)
NFFinder: an online bioinformatics tool for searching similar transcriptomics experiments in the context of drug repositioning
Javier Setoain et al.
NUCLEIC ACIDS RESEARCH (2015)
limma powers differential expression analyses for RNA-sequencing and microarray studies
Matthew E. Ritchie et al.
NUCLEIC ACIDS RESEARCH (2015)
Tissue-based map of the human proteome
Mathias Uhlen et al.
SCIENCE (2015)
The Molecular Signatures Database Hallmark Gene Set Collection
Arthur Liberzon et al.
CELL SYSTEMS (2015)
featureCounts: an efficient general purpose program for assigning sequence reads to genomic features
Yang Liao et al.
BIOINFORMATICS (2014)
Probabilistic drug connectivity mapping
Juuso A. Parkkinen et al.
BMC BIOINFORMATICS (2014)
Novel Drug Candidates for the Treatment of Metastatic Colorectal Cancer through Global Inverse Gene-Expression Profiling
Vera van Noort et al.
CANCER RESEARCH (2014)
Epidermal Growth Factor Receptor Inhibition Attenuates Liver Fibrosis and Development of Hepatocellular Carcinoma
Bryan C. Fuchs et al.
HEPATOLOGY (2014)
Pathogenesis of liver cirrhosis
Wen-Ce Zhou et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2014)
The interaction between mesenchymal stem cells and steroids during inflammation
X. Chen et al.
CELL DEATH & DISEASE (2014)
Systematic evaluation of connectivity map for disease indications
Jie Cheng et al.
GENOME MEDICINE (2014)
STAR: ultrafast universal RNA-seq aligner
Alexander Dobin et al.
BIOINFORMATICS (2013)
Homoharringtonine/Omacetaxine Mepesuccinate: The Long and Winding Road to Food and Drug Administration Approval
Hagop M. Kantarjian et al.
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA (2013)
In silico drug repositioning - what we need to know
Zhichao Liu et al.
DRUG DISCOVERY TODAY (2013)
Prognostic Gene Expression Signature for Patients With Hepatitis C-Related Early-Stage Cirrhosis
Yujin Hoshida et al.
GASTROENTEROLOGY (2013)
Prevention of Hepatocellular Carcinoma: Potential Targets, Experimental Models, and Clinical Challenges
Yujin Hoshida et al.
CURRENT CANCER DRUG TARGETS (2012)
Integrative Genomic Identification of Genes on 8p Associated With Hepatocellular Carcinoma Progression and Patient Survival
Stephanie Roessler et al.
GASTROENTEROLOGY (2012)
Sixty-five gene-based risk score classifier predicts overall survival in hepatocellular carcinoma
Soo Mi Kim et al.
HEPATOLOGY (2012)
Diagnosing the decline in pharmaceutical R&D efficiency
Jack W. Scannell et al.
NATURE REVIEWS DRUG DISCOVERY (2012)
Differential expression analysis of multifactor RNA-Seq experiments with respect to biological variation
Davis J. McCarthy et al.
NUCLEIC ACIDS RESEARCH (2012)
clusterProfiler: an R Package for Comparing Biological Themes Among Gene Clusters
Guangchuang Yu et al.
OMICS-A JOURNAL OF INTEGRATIVE BIOLOGY (2012)
RSEM: accurate transcript quantification from RNA-Seq data with or without a reference genome
Bo Li et al.
BMC BIOINFORMATICS (2011)
pROC: an open-source package for R and S plus to analyze and compare ROC curves
Xavier Robin et al.
BMC BIOINFORMATICS (2011)
Computational Repositioning of the Anticonvulsant Topiramate for Inflammatory Bowel Disease
Joel T. Dudley et al.
SCIENCE TRANSLATIONAL MEDICINE (2011)
Discovery of drug mode of action and drug repositioning from transcriptional responses
Francesco Iorio et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
lumi:: a pipeline for processing Illumina microarray
Pan Du et al.
BIOINFORMATICS (2008)
A simple and robust method for connecting small-molecule drugs using gene-expression signatures
Shu-Dong Zhang et al.
BMC BIOINFORMATICS (2008)
WGCNA: an R package for weighted correlation network analysis
Peter Langfelder et al.
BMC BIOINFORMATICS (2008)
Genome-wide molecular profiles of HCV-induced dysplasia and hepatocellular carcinoma
Elisa Wurmbach et al.
HEPATOLOGY (2007)
Gene expression-based chemical genomics identifies rapamycin as a modulator of MCL1 and glucocorticoid resistance
Guo Wei et al.
CANCER CELL (2006)
The connectivity map: Using gene-expression signatures to connect small molecules, genes, and disease
Justin Lamb et al.
SCIENCE (2006)
Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles
A Subramanian et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
affy -: analysis of Affymetrix GeneChip data at the probe level
L Gautier et al.
BIOINFORMATICS (2004)
Drug repositioning: Identifying and developing new uses for existing drugs
TT Ashburn et al.
NATURE REVIEWS DRUG DISCOVERY (2004)
Share Paper
